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INTRODUCTION 
In India, cervical cancer is a leading cancer among 
women with annual incidence of about 130,000 cases 
and 70-75,000 deaths
1
. Thus, India shares about one 
fourth of the global cervical cancer burden. A large 
number of risk factors are known to contribute to high 
incidence of this disease but most important of them 
are early age of marriage (<18 years), multiple sexual 
partners, multiple pregnancies, poor genital hygiene, 
smoking, use of oral contraceptives, religion, ethnicity, 
etc.
 2
 Natural products have been used as traditional 
medicines in many parts of the world like Egypt, 
China, Greece, and India from ancient times. It is from 
these medicinal plants which have immense medicinal 
values that the modern drugs been developed.
3
 
Triticum aestivum 
Wheat, (Triticum species) a cereal grass of the 
Gramineae (Poaceae) family, is the world's largest 
edible grain cereal-grass crop. It is commonly 60-150 
cm. in height, but may be as short as 30 cm. Stem is 
tufted, erect or semi-erect to prostrate, generally 
hollow with thin walls, in stem nodes are present 
generally 5-7 at 3-4 cm. Leaves are long and narrow 
having glabrous or hairy on one or both surface.
4,5
 
Scientific reports on nutritional analysis of wheatgrass 
have been published frequently in various journals 
6, 7, 
8
. These reports and the chemical analyses undertaken 
reveal that wheatgrass is rich in chlorophyll, minerals 
and trace elements including calcium, iodine, 
magnesium, selenium, zinc, chromium, antioxidants 
like betacarotene (pro-vitamin A), vitamin B1,  
vitamin E, vitamin C, antianemic factors like vitamin 
B12, iron, folic acid, pyridoxine and many other 
minerals, amino acids and enzymes, which have 
significant nutritious and medicinal value
4
. 
Wheatgrass is known to contain antioxidant enzymes 
superoxide dismutase (SOD) and cytochrome oxidase 
that have the potential to convert reactive oxygen 
species (ROS) to a hydrogen peroxide and an oxygen 
molecule
9
. Chlorophyll, one of the primary 
components in the wheatgrass, was found to augment 
blood formation and strengthen the immune system 
through inhibition of metabolic activation of 
carcinogens
10-11
. It also possesses the ability to inhibit 
oxidative DNA damage
12
.  
Dr. Ann Wigmore, founder director of the Hippocrates 
Health Institute, Boston, U.S.A., she claimed that 
wheatgrass is a safe and effective treatment for 
ailments such as high blood pressure, some cancers, 
obesity, diabetes, gastritis, ulcers, anemia, asthma and 
eczema 
13
. Few clinical trials have been accomplished 
that have shown on consumption of wheatgrass juice, 
the number of transfusions in patients with thalassemia 
major is decreased
14
. Reduction in the overall disease 
activity index and the severity of rectal bleeding in 
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cases of distal ulcerative colitis on consumption of 
wheatgrass juice has also been observed
15
. 
VERO Cell line 
The Vero lineage was isolated 
from kidney epithelial cells extracted from an African 
green monkey. The lineage was developed on 27 
March 1962, by Yasumura and Kawakita at the Chiba 
University in Chiba, Japan
16
. The original cell line was 
named "Vero" after an abbreviation of "Verda Reno", 
which means "green kidney" in esperanto, while 
"Vero" itself means "truth" also in Esperanto
17
. Vero 
cells are one of the most common mammalian 
continuous cell lines used in research
18
.  
HeLa cell line 
A HeLa cell is an immortal cell line used in medical 
research. The cell line was derived from cervical 
cancer cells taken from Henrietta Lacks, who died 
from her cancer in 1951. Initially, the cell line was said 
to be named after a "Helen Lane" in order to preserve 
Lacks's anonymity
19
. 
MATERIALS AND METHODS 
Plant Material 
Certified sample of Triticum aestivum (Wheatgrass), 
was acquired from Anand Agricultural University, 
Gujarat. The authenticity of this certified sample was 
also confirmed by comparing its morphological 
characters with the description mentioned in different 
standard texts and floras
20
. Voucher specimen of the 
plant has been deposited at Department of 
Pharmacognosy, B. Pharmacy College, Rampura, 
Kakanpura, Godhra, Dist. Panchmahal, Gujarat, India 
for future reference. This wheat variety was grown in 
plastic tray as per the standard procedure described 
below
13
. 
Procedure for growing wheatgrass 
 Adequate quantities of unpolished wheat grain 
were soaked overnight in water in a container. 
 On the next day, the soaked wheat-grain were 
spread on the surface of the soil filled in plastic 
trays. Care was taken so that the grains did not 
touch one another. 
 A thin layer of soil was sprinkled on the wheat 
grains and then tray was covered with a 
newspaper to provide darkness, which helps the 
sprouting. 
 The tray was kept in a covered balcony. Next day 
the tray was uncovered to spray on some water 
and was covered again with the newspaper. 
 Previous step was repeated every day until 
sprouting took place, after which the tray was left 
uncovered and watered everyday for 8 days. 
 On 9th day the wheatgrass was harvested by 
cutting it with a clean pair of scissors about 1/2" 
above the surface of the soil. 
Preparation of aqueous extract 
For preparation of aqueous extract, 100 g of fresh 
wheatgrass was crushed thoroughly, using mortar and 
pestle. The crushed wheatgrass was completely 
exhausted by adding small quantities of water several 
times followed by filtration, to yield final volume of 1 
liter. The extract was filtered and concentrated to 
dryness under reduced pressure and controlled 
temperature (40 ºC to 50 ºC) in a rotary evaporator.  
The dried extract was dissolved in Dimethyl 
sulphoxide (DMSO) to prepare the stock solution 100 
mg/ml. 
In-vitro evaluation of anticancer activity by MTT 
assay  
Cell culture  
The human cervical cancer cell line (HeLa) & Vero 
(normal kidney cells) was provided by National Centre 
for Cell Science (NCCS), Pune. Stock cells of these 
cell lines were cultured in DMEM (high glucose) or 
Eagle’s Minimum Essential Medium (EMEM) with 
10% fetal bovine serum (FBS). All cells were 
maintained at 37°C, 5% CO2, 95% air. Cells were 
used in experiments during the linear phase of growth. 
Preparation of working herbal extracts 
0.5ml of stock (100 mg/ml) herbal extract was 
dissolved in 4.5 ml of DMSO giving a concentration of 
10mg/ml. 10 µl of 10 mg conc. of test compound was 
added in to 900 µl of complete media and as a result 
100 µg conc. of test sample was obtained. Than 1:3 
dilution of test sample was done as shown in Table 1. 
It was done by mixing 50 µl of test compound with 
100 µl of complete media. For this, initially 100 µl of 
complete media was added in to well no. 1 – 9. Well 
10 contained 150 µl test substance only, from that 50 
µl was pipetted out and added into well no. 9 which 
already contain 100 µl of complete media, which lead 
to 1:3 dilution of test sample. Same procedure was 
repeated 9 times in order to get final conc. of test 
Sample up to 0.005 µm. (Table 1). 
Cytotoxicity assay 
Principle 
This Colorimetric assay is based on the capacity of 
Mitochondria succinate dehydrogenase enzymes in 
living cells to reduce the yellow water soluble 
substrate 3- (4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl 
tetrazolium bromide (MTT) into an insoluble, purple 
colored formazan product which is measured 
spectrophotometrically
21-23
. This formazan production 
is directly proportional to the viable cell number and 
inversely proportional to the degree of cytotoxicity
24-
25
. 
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Table 1: (1:3) dilution of test compound used in the assay 
Where, T.C= Test Compound; C.M= Culture Media 
 
MTT assay
20,23,26‐28 
Protocol: 
 Cells were preincubated at a concentration of 1 × 
1 0
6
 cells / ml in culture medium for 3 hrs at 37°C 
and 6.5 % CO2, 75 % Relative Humidity.  
 Cells were seeded at a concentration of 5 × 10 4 
cells / well in 100 µl culture medium and various 
amounts of compound (final concentration, e.g. 
1000 µg/ml – 0.05µg/ml) were added into 
microplates (tissue culture grade, 96 wells, flat 
bottom).  
 Cell cultures were incubated for 24 hrs at 37 °C 
and 6.5% CO2.  
 10 µl MTT labeling mixture was added and 
incubate for 4 hrs at 37 °C and 6.5 % CO2, 75 % 
Relative Humidity.  
 100 µl of solubilization solution was added to 
each well and incubate for overnight.  
 Absorbance of the samples was measured using a 
microplate (ELISA) reader. The wavelength to 
measure absorbance of the formazan product is 
between 540 and 600 nm according to the filters 
available for the ELISA reader, used. (The 
reference wavelength should be more than 650 
nm).  
 
DATA INTERPRETATION: 
Absorbance values that are lower than the control cells 
indicate a reduction in the rate of cell proliferation. 
Conversely a higher absorbance rate indicates an 
increase in cell proliferation. Rarely, an increase in 
proliferation may be offset by cell death; evidence of 
cell death may be inferred from morphological 
changes. 
After 24 hrs, the cytotoxicity data were evaluated by 
determining absorbance and calculating the 
correspondent chemical concentrations. Linear 
regression analysis with 95 % confidence limit and R
2
 
were used to define dose-response curves and to 
compute the concentration of chemical agents needed 
to reduce absorbance of the formazan by 50 % (IC50). 
Percentage cell growth inhibition or percentage 
cytotoxicity was calculated by following formula: 
% viability = (AT – AB) / (AC –  AB) × 100..… (1) 
Where, 
AT = Absorbance of treated cells (drug) 
AB = Absorbance of blank (only media) 
AC = Absorbance of control (untreated) 
There by, 
% cytotoxicity = 100 –  % cell survival …… (2)  
Cell viability % = Mean OD of wells receiving each 
plant extract dilution/ Mean OD of control wells x 100 
…….(3) 
Cell death % = 1 – (OD of sample/OD of control) x 
100…(4) 
 
DETERMINATION OF IC50 VALUE:  
According to the FDA, IC50 represents the 
concentration of a drug that is required for 50 % 
inhibition in-vitro. In the present study, IC50 is a 
concentration of drug at which 50 % of cell population 
die. 
For primary screening, a threshold of 50 % cell growth 
inhibition as a cut off for compound toxicity against 
cell lines. IC50 determined from plot of Dose Response 
curve between log of compound concentration and 
percentage growth inhibition. IC50 values have been 
derived using curve fitting methods with GraphPad 
Prism as statistical software (Ver. 5.02). 
IC50 values were calculated using the nonlinear 
regression program Origin The average of two 
(duplicates manner) were taken in determination. 
Graph was plotted by keeping log concentration of 
drug on X axis and % cell growth inhibition or % 
cytotoxicity Y axis. IC50 was estimated as a 
concentration of the drug at 50 % position on the Y 
axis. 
The relationship should be sigmoidal, log drug 
concentration on the X axis and 'response / 
well no:1-9 contain  complete media 100  µl + Test Compound 30  µl 
Well no: 1 2 3 4 5 6 7 8 9 10 
Compound 
dilution 
50 µl 
T.C  
from 
well   
2 
50 µl 
T.C 
from 
well 3 
50 µl 
T.C 
from 
well    
4 
50 µl 
T.C 
from 
well 5 
50µl 
T.C 
from 
well6 
50µl 
T.C 
from 
well 7 
50µl 
T.C 
from 
well 8 
50µl 
T.C 
from 
well  
9 
50µl 
T.C 
from 
well 
10 
150µl 
T.C 
Final conc.  (µm) 
0.05 
µg  
0.15  
µg 
0.46  
µg 
1.37  
µg 
4.12  
µg 
12.35 
µg 
37.04  
µg 
111.1  
 µg 
333.3  
µg 
1000 
µg 
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measurement' of the Y axis. The prism web site has 
some good guides for this. 
RESULTS AND DISCUSSION 
In order to evaluate the cytotoxic effect of aqueous 
extract of Triticum aestivum, a MTT assay with HeLa 
(human cervical cancer) & Vero (normal kidney cells) 
cell line was performed. The extract was screened for 
its cytotoxicity at different concentrations to determine 
the IC50 (50% growth inhibition) value.   
A chart was plotted using the % cell inhibition in 
Y‐axis and concentration of the plant extract in X‐axis. 
The results are tabulated in (Table 2) and graphically 
represented (Fig. 1).   
When HeLa and VERO cells were treated with the 
aqueous extract of the leaves of Triticum aestivum, 
there was a concentration dependent cytotoxic effect. 
As the concentration increased from 0.05 – 10,000 
μg/ml, percentage of inhibition increases from -
93.85% to 37.49 for VERO cell line and -6.66% to 
63.2 % for HeLa cell line.   The IC50 value was found 
to be 1000 μg/ml for VERO cell line and 133.6 μg/ml 
for HeLa cell line from the graph and R
2
 values 0.9783 
for VERO cell line and 0.9071for HeLa cell line 
(Table 3). 
  
Table 2: % Cell inhibition on VERO & HeLa cell lines by aqueous extract of leaves of Triticum aestivum 
  
 
 
Figure 1: Dose response curve of aqueous extract of leaves of Triticum aestivum on HeLa and VERO-cell-lines. 
Table 3:  IC50 and R
2
 values of aqueous extract of leaves of Triticum aestivum 
 
 
 
 
Sr.No Concentration (µg/ml) Log conc VERO HeLa 
1 0.05 -1.29 -93.85 -6.66 
2 0.15 -0.82 -116.4 -11.75 
3 0.46 -0.34 -115 -13.57 
4 1.37 0.14 -115.6 -11.38 
5 4.12 0.61 -115.4 -14.74 
6 12.35 1.09 -114 -16.58 
7 37.04 1.57 -91.66 -15.43 
8 111.11 2.05 -60.82 42.79 
9 333.33 2.52 1.28 63.06 
10 1000 3 37.49 63.2 
Parameters VERO HeLa 
IC50 Value 1000 133.6 
R
2
 0.9783 0.9071 
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Traditionally many medicinal plants, which possess the 
ability to prevent and even to stall the progress of 
cancer, were in use. Plants possess certain chemicals, 
which have the ability to modify the physiological 
function of cells and hence act as anti‐cancer drugs to 
arrest the proliferation of cancer cells. The mode of 
action of the drugs is unknown but successfully 
integrating our documented knowledge of plant 
properties and modern technological tools, effective 
anti‐cancer drugs can be derived from plant sources 
and their mechanism can be elucidated
29-31
. 
The present need is to develop drugs that can 
potentially target cancer cells by means of their 
inherent difference to normal cells. The development 
of such drugs with differential action will be very 
valuable in cancer chemotherapy without the observed 
side effects. The methodology involves use of cancer 
cell lines to test the efficacy of the plant extracts in 
vitro. 
The potential use of Triticum aestivum as therapeutic 
agent holds great promise as the isolation of one or 
more cytotoxic chemicals from crude extract and the 
judicious use of such chemicals can control the 
progression of cancer and also can prevent the 
formation of tumour in individuals who are highly 
susceptible to developing a tumour. 
CONCLUSION  
The results obtained from the in-vitro studies 
performed using the HeLa cell lines reveals that the 
aqueous extract of Triticum aestivum has a moderate 
anticancer activity. The extract did not show any cell 
toxic potential to the normal cell line i.e. Vero cell line. 
Even though there was increase in the cell growth 
inhibition when concentration of sample was increased, 
the IC50 value was 133.6 μg/ml for the HeLa cell line 
as shown by the MTT assay method. This holds great 
promise for future research in human beings. The 
anticancer property of Triticum aestivum will provide 
useful information in the possible application in the 
prevention and treatment of cancer. 
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